Literature DB >> 29917167

Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1.

Xiaowei Diao1, Xiubin Chen2, Yurui Pi2, Yu Zhang2, Fangfang Wang2, Ping Liu2, Yanhong Gao2, Xiaojun Wang2, Sijun Yang3, Shan Lu2.   

Abstract

Erythropoietin‑producing hepatocellular carcinoma cell surface type‑A receptor 3 (EPHA3) has been found to promote the proliferation and survival of prostate cancer (PCa) cell lines and prostate tumor development in nude mice. However, the regulation of EPHA3 in PCa remains largely unknown. This study is aimed to investigate the association between EPHA3 expression and androgen receptor (AR) signaling and the potential mechanism. We determined mRNA and protein levels of EPHA3 and AR signaling‑related genes in the PCa cell line 22Rv1 by reverse transcription‑polymerase chain reaction (RT‑PCR) and western blotting, respectively. The EPHA3 mRNA and protein levels were both found to be elevated by dihydrotestosterone (DHT) hormone in a dose‑ and time‑dependent manner, as AR and prostate‑specific antigen (PSA) expression were increased. Similarly, EPHA3 protein levels were also increased in the PCa cell line LNCaP stimulated with DHT or mibolerone (Mib). Overexpression of pEGFP‑AR in 22Rv1 cells significantly increased the EphA3 level, while AR knockdown with small interfering RNA (siRNA) for AR (siAR) markedly decreased the expression of EPHA3. The key EPHA3 promoter region associated with AR regulation was evaluated by co‑transfection of various pGL3‑basic‑luciferase reporter plasmids, containing EPHA3 core promoter fragments differing in length, with the AR plasmid or siAR into 22Rv1 cells. AR overexpression in 22Rvl cells raised the EphA3 promoter transcription activity of pGL3EPHA3‑Luc (EPHA3‑Luc)‑789, and vice versa. Similarly, luciferase activity of EPHA3‑Luc‑317 was also clearly affected. However, truncated EPHA3‑Luc‑237 without the transcription factor specific protein 1 (SP1) binding sites or EPHA3‑Luc‑789ΔSP1 with modified SP1 binding sites clearly decreased EPHA3 promoter activity regardless of whether AR was overexpressed or blocked. Treatment of 22Rv1 cells with 10 and 100 nM of the SP1 inhibitor mithramycin A for 24 and 48 h significantly reduced EPHA3 mRNA and protein levels. Additionally, selective inhibition of SP1 with siRNA SP1 (siSP1) at various concentration from 25 to 75 nM, reduced the EPHA3 protein level in PCa LNCaP cells, accordingly. Co‑immunoprecipitation (co‑IP) and chromatin IP (ChIP) assays were performed to determine whether AR forms a transcription factor complex with Sp1 that binds the EPHA3 core promoter region to sense androgen induction. The result suggests that the interaction of AR and SP1 contributes to regulate EPHA3 expression, and the SP1 binding sites (‑295~‑261) in the EPHA3 core promoter region is crucial to the regulation of EPHA3 expression in response to androgen hormone stimuli.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29917167     DOI: 10.3892/or.2018.6503

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility.

Authors:  Marwah M Al-Mathkour; Abdulrahman M Dwead; Esma Alp; Ava M Boston; Bekir Cinar
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

2.  Klotho is regulated by transcription factor Sp1 in renal tubular epithelial cells.

Authors:  Yan Li; Yong Liu; Kailong Wang; Yinghui Huang; Wenhao Han; Jiachuan Xiong; Ke Yang; Mingying Liu; Tangli Xiao; Chi Liu; Ting He; Xianjin Bi; Jingbo Zhang; Bo Zhang; Jinghong Zhao
Journal:  BMC Mol Cell Biol       Date:  2020-06-22

3.  The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy.

Authors:  Xiuzhi Duan; Xiaoming Xu; Binbin Yin; Bong Hong; Weiwei Liu; Qian Liu; Zhihua Tao
Journal:  J Clin Lab Anal       Date:  2019-04-08       Impact factor: 2.352

4.  P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice.

Authors:  Tonghui Li; Fangfang Wang; Yanmei Dang; Jiajie Dong; Yu Zhang; Chi Zhang; Ping Liu; Yanhong Gao; Xiaojun Wang; Sijun Yang; Shan Lu
Journal:  Int J Biol Sci       Date:  2019-08-19       Impact factor: 6.580

5.  MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.

Authors:  Hannah Weber; Rachel Ruoff; Michael J Garabedian
Journal:  PLoS Genet       Date:  2021-01-29       Impact factor: 5.917

6.  The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells.

Authors:  Austin McDermott; KyoungHyun Kim; Susan Kasper; Shuk-Mei Ho; Yuet-Kin Leung
Journal:  Oncotarget       Date:  2022-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.